Intrust Bank’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.98M | Buy |
10,038
+1,582
| +19% | +$305K | 0.16% | 105 |
|
|
2025
Q4 | $1.55M | Buy |
8,456
+300
| +4% | +$52.6K | 0.13% | 117 |
|
|
2025
Q3 | $1.25M | Buy |
8,156
+388
| +5% | +$58.7K | 0.1% | 144 |
|
|
2025
Q2 | $1.09M | Sell |
7,768
-142
| -2% | -$19.9K | 0.1% | 148 |
|
|
2025
Q1 | $1.16M | Buy |
7,910
+882
| +13% | +$128K | 0.12% | 139 |
|
|
2024
Q4 | $921K | Buy |
7,028
+174
| +3% | +$24.4K | 0.09% | 160 |
|
|
2024
Q3 | $1.07M | Buy |
6,854
+400
| +6% | +$64.6K | 0.11% | 147 |
|
|
2024
Q2 | $1.01M | Buy |
6,454
+506
| +9% | +$76.1K | 0.11% | 147 |
|
|
2024
Q1 | $806K | Sell |
5,948
-573
| -9% | -$75.9K | 0.09% | 186 |
|
|
2023
Q4 | $878K | Sell |
6,521
-33
| -0.5% | -$4.29K | 0.1% | 167 |
|
|
2023
Q3 | $888K | Buy |
6,554
+219
| +3% | +$29.9K | 0.11% | 151 |
|
|
2023
Q2 | $907K | Buy |
6,335
+144
| +2% | +$21.2K | 0.11% | 159 |
|
|
2023
Q1 | $859K | Buy |
6,191
+501
| +9% | +$67.4K | 0.11% | 159 |
|
|
2022
Q4 | $771K | Buy |
5,690
+765
| +16% | +$95.9K | 0.11% | 166 |
|
|
2022
Q3 | $540K | Sell |
4,925
-1,233
| -20% | -$156K | 0.08% | 208 |
|
|
2022
Q2 | $814K | Buy |
6,158
+310
| +5% | +$40.7K | 0.12% | 153 |
|
|
2022
Q1 | $775K | Buy |
5,848
+1,067
| +22% | +$128K | 0.1% | 187 |
|
|
2021
Q4 | $557K | Buy |
4,781
+16
| +0.3% | +$1.88K | 0.07% | 223 |
|
|
2021
Q3 | $572K | Buy |
4,765
+2,013
| +73% | +$234K | 0.08% | 215 |
|
|
2021
Q2 | $330K | Buy |
2,752
+193
| +8% | +$21.2K | 0.04% | 288 |
|
|
2021
Q1 | $254K | Buy |
+2,559
| New | +$257K | 0.04% | 327 |
|
|
2020
Q4 | – | Sell |
-1,893
| Closed | -$207K | – | 366 |
|
|
2020
Q3 | $207K | Hold |
1,893
| – | – | 0.04% | 322 |
|
|
2020
Q2 | $200K | Sell |
1,893
-468
| -20% | -$48.3K | 0.04% | 315 |
|
|
2020
Q1 | $211K | Hold |
2,361
| – | – | 0.06% | 291 |
|
|
2019
Q4 | $236K | Sell |
2,361
-33
| -1% | -$3.11K | 0.05% | 306 |
|
|
2019
Q3 | $214K | Sell |
2,394
-328
| -12% | -$28.4K | 0.05% | 321 |
|
|
2019
Q2 | $225K | Sell |
2,722
-497
| -15% | -$39K | 0.05% | 325 |
|
|
2019
Q1 | $261K | Sell |
3,219
-1,035
| -24% | -$81.6K | 0.07% | 330 |
|
|
2018
Q4 | $324K | Sell |
4,254
-436
| -9% | -$34K | 0.09% | 249 |
|
|
2018
Q3 | $372K | Sell |
4,690
-431
| -8% | -$32.6K | 0.09% | 253 |
|
|
2018
Q2 | $360K | Sell |
5,121
-220
| -4% | -$15.8K | 0.1% | 252 |
|
|
2018
Q1 | $374K | Sell |
5,341
-1,359
| -20% | -$94.1K | 0.11% | 245 |
|
|
2017
Q4 | $465K | Buy |
6,700
+379
| +6% | +$25.6K | 0.14% | 216 |
|
|
2017
Q3 | $428K | Buy |
6,321
+36
| +0.6% | +$2.27K | 0.14% | 212 |
|
|
2017
Q2 | $429K | Sell |
6,285
-1,928
| -23% | -$126K | 0.15% | 200 |
|
|
2017
Q1 | $512K | Sell |
8,213
-7,841
| -49% | -$456K | 0.18% | 166 |
|
|
2016
Q4 | $877K | Sell |
16,054
-7,108
| -31% | -$404K | 0.33% | 84 |
|
|
2016
Q3 | $1.52M | Sell |
23,162
-1,492
| -6% | -$97.5K | 0.61% | 33 |
|
|
2016
Q2 | $1.49M | Buy |
24,654
+3,498
| +17% | +$203K | 0.6% | 33 |
|
|
2016
Q1 | $1.19M | Buy |
21,156
+5,890
| +39% | +$354K | 0.43% | 81 |
|
|
2015
Q4 | $1.04M | Buy |
15,266
+895
| +6% | +$58.7K | 0.39% | 87 |
|
|
2015
Q3 | $915K | Buy |
14,371
+10,261
| +250% | +$675K | 0.35% | 94 |
|
|
2015
Q2 | $262K | Buy |
+4,110
| New | +$281K | 0.09% | 237 |
|
|
2015
Q1 | – | Sell |
-3,391
| Closed | -$239K | – | 258 |
|
|
2014
Q4 | $239K | Sell |
3,391
-1,335
| -28% | -$95.6K | 0.09% | 239 |
|
|
2014
Q3 | $338K | Sell |
4,726
-805
| -15% | -$58.9K | 0.13% | 185 |
|
|
2014
Q2 | $411K | Sell |
5,531
-4,638
| -46% | -$335K | 0.15% | 184 |
|
|
2014
Q1 | $660K | Sell |
10,169
-1,099
| -10% | -$71K | 0.27% | 111 |
|
|
2013
Q4 | $669K | Sell |
11,268
-85
| -0.7% | -$4.62K | 0.29% | 108 |
|
|
2013
Q3 | $590K | Sell |
11,353
-200
| -2% | -$10K | 0.28% | 113 |
|
|
2013
Q2 | $547K | Buy |
+11,553
| New | +$588K | 0.24% | 144 |
|
Other funds holding AZN
IA
VCM
VAM
Intrust Bank's AZN Position: Q1 2026 in Review
Intrust Bank increased its AstraZeneca (AZN) stake by 19% in Q1 2026, buying an estimated $305K and bringing the position to 10,038 shares worth $1.98M. The position accounts for 0.16% of the portfolio, ranked #105.
Intrust Bank first reported a position in AZN in Q2 2013 and has held it in 50 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Intrust Bank held 10,038 shares of AstraZeneca worth $1.98M as of Q1 2026.
- Intrust Bank bought 1,582 AstraZeneca shares in Q1 2026, an estimated $305K.
- AstraZeneca made up 0.16% of Intrust Bank's portfolio in Q1 2026, its #105 holding.
- Intrust Bank first reported a position in AstraZeneca in Q2 2013 and has held it in 50 quarters since.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Intrust Bank's 13F filing for Q1 2026, filed 6 May 2026.